We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.74%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$309B
AUM Growth
-$29.4B
(-8.7%)
Cap. Flow
-$6.3B
Cap. Flow
% of AUM
-2.04%
Top 10 Holdings %
Top 10 Hldgs %
22.53%
Holding
3,477
New
138
Increased
1,588
Reduced
1,481
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$949M |
| 2 |
EOG Resources
EOG
|
+$470M |
| 3 |
Mastercard
MA
|
+$453M |
| 4 |
Las Vegas Sands
LVS
|
+$413M |
| 5 |
Booking.com
BKNG
|
+$413M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$712M |
| 2 |
Meta Platforms (Facebook)
META
|
+$565M |
| 3 |
PayPal
PYPL
|
+$556M |
| 4 |
Morgan Stanley
MS
|
+$541M |
| 5 |
Pfizer
PFE
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.81% |
| 2 | Financials | 12.45% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CINC
3101
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $284K | ﹤0.01% |
+16,179
| New | +$332K |
|
|
ICAD
3102
DELISTED
iCAD Inc
ICAD
| $278K | ﹤0.01% |
68,869
| – | – |
|
|
TBHC
3103
DELISTED
The Brand House Collective
TBHC
| $278K | ﹤0.01% |
24,921
-8,236
| -25% | -$117K |
|
3104
IBEX
IBEX
$499M
| $277K | ﹤0.01% |
17,362
-7,637
| -31% | -$114K |
|
3105
Verrica Pharmaceuticals
VRCA
$87.3M
| $277K | ﹤0.01% |
3,279
| – | – |
|
3106
American Coastal Insurance
ACIC
$494M
| $275K | ﹤0.01% |
77,754
+1,538
| +2% | +$5.82K |
|
3107
ARS Pharmaceuticals
SPRY
$612M
| $272K | ﹤0.01% |
64,723
+1,433
| +2% | +$6.24K |
|
|
PNT
3108
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $271K | ﹤0.01% |
+41,817
| New | +$266K |
|
3109
Black Diamond Therapeutics
BDTX
$112M
| $268K | ﹤0.01% |
86,043
+1,996
| +2% | +$7.29K |
|
|
LX
3110
LexinFintech Holdings
LX
$241M
| $268K | ﹤0.01% |
102,200
-7,600
| -7% | -$25.2K |
|
|
EH
3111
EHang Holdings
EH
$435M
| $267K | ﹤0.01% |
22,300
-1,700
| -7% | -$24.6K |
|
|
SHCO
3112
DELISTED
Soho House & Co
SHCO
| $266K | ﹤0.01% |
+34,499
| New | +$304K |
|
3113
Solid Biosciences
SLDB
$826M
| $266K | ﹤0.01% |
13,877
-26,907
| -66% | -$475K |
|
3114
Neuronetics
STIM
$166M
| $264K | ﹤0.01% |
79,147
+11
| +0% | +$37 |
|
3115
Western Midstream Partners
WES
$19.3B
| $263K | ﹤0.01% |
+10,724
| New | +$264K |
|
3116
Zymeworks
ZYME
$1.73B
| $254K | ﹤0.01% |
36,322
+3,008
| +9% | +$26.8K |
|
|
DAO
3117
Youdao
DAO
$2.19B
| $252K | ﹤0.01% |
35,500
-2,800
| -7% | -$31.8K |
|
3118
Neurogene
NGNE
$712M
| $252K | ﹤0.01% |
6,533
+74
| +1% | +$4.32K |
|
|
TRVN
3119
DELISTED
Trevena, Inc.
TRVN
| $251K | ﹤0.01% |
823
| – | – |
|
3120
KALA BIO
KALA
$14.5M
| $250K | ﹤0.01% |
65
| – | – |
|
3121
The Beachbody Company
BODI
$74.8M
| $247K | ﹤0.01% |
+2,263
| New | +$230K |
|
|
UXIN
3122
Uxin Ltd
UXIN
$282M
| $244K | ﹤0.01% |
2,393
-189
| -7% | -$21.6K |
|
3123
1stdibs.com
DIBS
$171M
| $243K | ﹤0.01% |
+28,633
| New | +$275K |
|
3124
Fortress Biotech
FBIO
$88.7M
| $243K | ﹤0.01% |
11,438
+34
| +0.3% | +$931 |
|
|
PLM
3125
DELISTED
PolyMet Mining Corp.
PLM
| $239K | ﹤0.01% |
69,197
-125
| -0.2% | -$359 |
|
Similar funds
VFT
Nuveen's Q1 2022 Portfolio in Review
As of Q1 2022, Nuveen held 3,477 positions worth $309B, down 8.7% from $338B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q1 2022 filing shows 138 new, 1,588 increased, 1,481 reduced and 89 closed positions. Its largest new stake was Constellation Energy: 1,208,173 shares worth $59.5M. The largest sale was Qualcomm, an estimated $712M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q1 2022 buy was Constellation Energy: 1,208,173 shares worth $59.5M.
- Nuveen added most to Advanced Micro Devices in Q1 2022, an estimated $949M increase.
- Nuveen's biggest Q1 2022 reduction was Qualcomm, cutting an estimated $712M.
- Nuveen fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $264M.
- Nuveen's ten largest holdings make up 23% of its $309B portfolio in Q1 2022.
- Nuveen opened 138 new positions and closed 89 in Q1 2022.
- Nuveen's portfolio value fell 8.7% quarter-over-quarter to $309B.
Based on Nuveen's 13F filing for Q1 2022, filed 16 May 2022.